Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
Sarah V. Leavitt
, Karen R. Jacobson, Elizabeth J. Ragan, Jacob Bor, Jennifer Hughes, Tara C. Bouton, Tania Dolby, Robin M. Warren, and Helen E. Jenkins
Author affiliations: Boston University, Boston, Massachusetts, USA (S.V. Leavitt, K.R. Jacobson, E.J. Ragan, J. Bor, T.C. Bouton, H.E. Jenkins); Boston Medical Center, Boston (K.R. Jacobson, E.J. Ragan, T.C. Bouton); University of the Witwatersrand, Johannesburg, South Africa (J. Bor); Stellenbosch University, Stellenbosch, South Africa (J. Hughes, R.M. Warren); Brown University, Providence, Rhode Island, USA (T.C. Bouton); Green Point Tuberculosis Laboratory, Cape Town, South Africa (T. Dolby); South African Medical Research Council Centre for Tuberculosis Research, Cape Town (R.M. Warren); Department of Science and Technology–National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Cape Town (R.M. Warren)
Figure 1. Flow diagram showing identification of adult patients with RR TB, Western Cape, South Africa, 2012–2014. Patients did not have second-line drug resistance and attended >2 clinic visits. The following test results were classed as inconclusive: inconclusive, error, unsuccessful, specimen container received empty, no result, lost viability, contaminated, specimen accidentally destroyed, insufficient specimen, or leaky specimen. The total number of patients excluded does not equal the sum of the individual categories because some patients belonged to multiple groups. RR, rifampin-resistant; TB, tuberculosis.
Page created: January 29, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.